Given that deregulated MYCN expression is known to dominate the active cis-regulatory landscape of MNA NB tumors (34), we therefore reasoned that focusing on nMNA tumors may provide us with a better opportunity to identify additional oncogenic factors promoting the most aggressive state of this disease. This evidence concerns the gene MYCN and neuroblastoma.